Open AccessPotentiation of Efficacy of Chimeric Antigen Receptor (CAR) T-cell Therapy in Hematological Malignancies using FDA-Approved Small Molecule Sensitizing Agents
Publication year - 2022
Publication title -
advances in hematology and oncology research
Language(s) - English
Resource type - Journals
ISSN - 2692-5516
DOI - 10.33140/ahor.05.01.03
Subject(s) - chimeric antigen receptor , chop , medicine , cancer research , vincristine , lymphoma , cd20 , b cell , rituximab , immunology , pharmacology , t cell , chemotherapy , cyclophosphamide , antibody , immune system
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom